XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net sales $ 229,148 $ 247,231 $ 703,816 $ 747,467
Cost of sales 148,788 169,167 464,138 497,491
Gross margin 80,360 78,064 239,678 249,976
Selling, general and administrative expenses 44,336 50,653 150,549 164,496
Research and development expenses 7,827 9,140 25,511 25,450
Restructuring and impairment charges 1,921 373 16,361 1,119
Other operating (income) expense, net (846) (578) (7,507) (2,852)
Operating income 27,122 18,476 54,764 61,763
Equity income in unconsolidated joint ventures 641 1,162 1,559 4,237
Other income (expense), net 761 977 9 1,563
Interest expense, net (2,328) (2,942) (8,627) (5,559)
Income before income taxes 26,196 17,673 47,705 62,004
Income tax expense (benefit) 7,161 2,835 14,311 12,683
Net income $ 19,035 $ 14,838 $ 33,394 $ 49,321
Basic earnings per share (in dollars per share) $ 1.02 $ 0.79 $ 1.79 $ 2.62
Diluted earnings per share (in dollars per share) $ 1.02 $ 0.78 $ 1.79 $ 2.60
Shares used in computing:        
Basic earnings per share (in shares) 18,627 18,818 18,619 18,804
Diluted earnings per share (in shares) 18,685 18,999 18,668 18,997